SV
LVGO

Sapphire Ventures’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Sapphire Ventures’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-875,628
Closed -$65.8M – 5
2020
Q2 		$65.8M Sell
875,628
-3,288,873
-79% -$172M 99.58% 1
2020
Q1 		$119M Hold
4,164,501
– – 77.89% 1
2019
Q4 		$104M Buy
+4,164,501
New +$99.6M 98.71% 1

Other funds holding LVGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sapphire Ventures's LVGO Position: Q3 2020 in Review

Sapphire Ventures sold out of Livongo Health, Inc. Common Stock (LVGO) in Q3 2020, closing a stake of 875,628 shares — an estimated $65.8M sold.

Sapphire Ventures first reported a position in LVGO in Q4 2019 and held it in 3 quarters. The position peaked at $119M in Q1 2020. 391 funds tracked by Wall St. Rank hold LVGO as of Q3 2020.

  • Sapphire Ventures reported no remaining Livongo Health, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Sapphire Ventures sold 875,628 Livongo Health, Inc. Common Stock shares in Q3 2020, an estimated $65.8M.
  • Sapphire Ventures first reported a position in Livongo Health, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Sapphire Ventures's Livongo Health, Inc. Common Stock position peaked at $119M in Q1 2020.
  • 391 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q3 2020.

Based on Sapphire Ventures's 13F filing for Q3 2020, filed 16 Nov 2020.